Survival of Lubinus straight (IP) and curved (SP) total hip prostheses in 543 patients after 4-13 years.

The clinical outcome and survival of 543 total hip arthroplasties with Lubinus cemented total hip prostheses after a mean of 7.9 years are reported. Clinical evaluation revealed no significant differences between patients with a straight stem and those with a curved anatomic stem. Loosening was statistically associated with young age, male sex, heavy weight, diagnosis other than osteoarthritis and year of operation. Survivorship analysis of the Lubinus IP implant at 8 years revealed a 95% chance of survival. The survival of the SP implant was 96%. After this time point the curve for SP implants began to fall at a faster rate than that for IP implants.

Clinical outcome and survival of Link RS total hip prosthesis.

We report the clinical outcome and survival of 100 total hip arthroplasties with Link RS cementless hip prostheses after a mean of 63 months (51 to 93). The average preoperative Merle d'Aubigné hip score was 9.4 points and the average score at the latest follow-up was 15.3 points. Thirteen prostheses have been revised and seven await revision. Survivorship analysis based on intention to revise showed only 68% survival at seven years (95% CI 53% to 81%). The survivals of femoral and acetabular components verified to be loose at surgery were 78% and 89% respectively at seven years. A number of other patients have pain and it seems likely that there will be substantial reduction in these survival figures in the future.